-
Abstract Number: OC 26.2
A dose-escalation phase 1 clinical trial of autologous iPSC-derived platelets (iPLAT1)
-
Abstract Number: PB1239
A Familial Case of MYH9 Gene Mutation Associated with Impaired Platelet Functionality and Structural Alterations
-
Abstract Number: PO0012
A frequency of anti-PF4/heparin antibodies and LA in patients with COVID-19
-
Abstract Number: OC 37.4
A humanized mouse model to assess the therapeutic potential of IdeS in hemophilia A with inhibitors
-
Abstract Number: PB1113
A method for measuring chromogenic factor VIII activity unbiased by the presence of the bispecific antibody Emicizumab
-
Abstract Number: OC 49.3
A microfluidic model to study the initiation of venous thrombosis
-
Abstract Number: PB0051
A Multicenter Cohort Study of COVID-19 Associated Venous Thromboembolism in Admitted Patients Followed Longitudinally 3-Months After Discharge
-
Abstract Number: OC 13.5
A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico study
-
Abstract Number: VPB0141
A near real-time surveillance algorithm to identify in-hospital VITT cases
-
Abstract Number: PB0666
A new FVIII chromogenic assay with bovine FX is sensitive enough for the diagnosis of severe haemophilia A.
-
Abstract Number: OC 44.3
A new mouse model of impaired fibrin α-chain crosslinking shows increased venous thrombembolism
-
Abstract Number: PB0804
A new type 1 von Willebrand Disease (VWD) characterized by increased clearance of von Willebrand Factor (VWF) due to the heterozygous p.P1127S mutation: clinical phenotype and pathogenic mechanisms.
-
Abstract Number: OC 41.5
A novel and unique mechanism of αIIbβ3 regulation in platelets
-
Abstract Number: PB0295
A Novel Assay to Investigate Thrombogenesis in TTP Patients
-
Abstract Number: PB1186
A novel chemiluminescent-based Thrombin Generation Assay for near-patient monitoring.
-
Abstract Number: PB0711
A novel homozygous KLKB1 missense variant causative of severe Prekallikrein deficiency.
-
Abstract Number: PB1001
A Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Hemostatic and Anti-Inflammatory Activities
-
Abstract Number: VPB1116
A novel material for the improvement of HIT detection
-
Abstract Number: OC 10.3
A novel model of RUNX1-haploinsufficient (RUNX1Lo): Human megakaryocytes infused into mice further characterizes this defect and identifies potential therapeutics
-
Abstract Number: PB1111
A novel prothrombin R533Q variant in patient with recurrent venous thrombosis
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 94
- Next Page »